Dr. Ohmini Krishnamurthy Rajendran: Advancing Precision Oncology Through Artificial Intelligence
- S. Adam
- 1 day ago
- 3 min read
S Adam, Jadetimes staff
Artificial intelligence is rapidly transforming healthcare, and among the emerging physician-scientists driving this evolution is Dr. Ohmini Krishnamurthy Rajendran, a Consultant Radiologist and AI researcher whose work bridges radiology, genomics, pathology, and computational medicine. Through a growing body of peer-reviewed research, academic publications, and innovation in cancer intelligence systems, Dr. Rajendran is contributing to the future of precision oncology.
Holding an MD in Radiodiagnosis, Dr. Rajendran combines clinical expertise with artificial intelligence research to develop intelligent systems capable of improving cancer diagnosis, prognosis, and personalized treatment planning. Her work focuses on integrating multimodal medical data including radiological imaging, pathology, genomics, and clinical records to support more accurate and data driven clinical decision-making.
Research Addressing the Future of Cancer Care
Dr. Rajendran has authored 16 peer-reviewed research papers exploring the application of AI across oncology, radiology, radiogenomics, and precision medicine. Her recent publications investigate several emerging areas shaping the future of healthcare, including:
AI-based radiogenomic models for predicting immunotherapy response in solid tumors.
Federated AI systems that enable hospitals to collaboratively train cancer diagnosis models without sharing sensitive patient data.
Self-supervised multimodal learning for early cancer detection using imaging and genomic information.
Deep learning techniques connecting histopathology and radiological imaging.
Digital twin frameworks designed to model individual cancer progression using longitudinal patient data.
Foundation model-driven precision oncology integrating multi-omics, radiology, and clinical information.
Clinical implementation of AI in oncology through workflow integration and real-world validation.
Generative AI methods for synthetic medical image generation to address limited training datasets.
Graph neural network approaches for survival prediction using whole-slide pathology images.
Explainable AI systems supporting transparent clinical decision-making.
Machine learning models for predicting chemotherapy toxicity in colorectal cancer.
Deep reinforcement learning applications in radiotherapy and personalized cancer treatment.
AI-driven drug repurposing and cancer drug response prediction using multi-omics data.
Collectively, these studies reflect a multidisciplinary approach aimed at improving cancer diagnosis, treatment planning, and clinical outcomes through advanced computational methods.
Beyond Publications
In addition to her journal articles, Dr. Rajendran has authored six academic books covering subjects such as multimodal AI, radiogenomics, digital twins, and precision oncology. She has also filed multiple Indian utility patents and a pending U.S. patent focused on AI-enabled cancer intelligence systems and cognitive radiogenomic platforms.
Her professional work extends beyond research. As a Consultant Radiologist, she contributes to diagnostic imaging across CT, MRI, ultrasound, and X-ray while collaborating with multidisciplinary teams involved in cancer diagnosis and treatment. Her clinical practice complements her research by ensuring that technological innovation remains closely aligned with real-world patient care.
A Vision for AI-Powered Precision Medicine
Modern oncology increasingly depends on integrating diverse medical information to provide personalized care. Dr. Rajendran's research emphasizes the convergence of artificial intelligence, radiology, genomics, pathology, and clinical medicine to create intelligent decision-support systems capable of assisting physicians throughout the cancer care pathway.
Her work also addresses important challenges surrounding explainable AI, ethical implementation, fairness in machine learning, and secure collaborative AI development, reflecting the growing importance of responsible innovation in healthcare.
Looking Ahead
As artificial intelligence continues to reshape global medicine, researchers like Dr. Ohmini Krishnamurthy Rajendran represent a new generation of clinician-scientists working at the intersection of healthcare and computational science. Through her research in multimodal AI, radiogenomics, digital twin technologies, and precision oncology, she is contributing to ongoing efforts to make cancer diagnosis and treatment more personalized, efficient, and data-driven.
With continued collaboration between clinicians, engineers, and data scientists, innovations in AI-powered oncology have the potential to improve patient care and support the next era of precision medicine worldwide.
Comments